Source comparison
Quickcomparison
Dose Range Melanotan-2 100–500 mcg PT-141 (Bremelanotide) 1.75–2 mg Frequency Once daily As needed Administration Subcutaneous injection Cycle Length 4-6 weeks Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Rapid (hours to days) Evidence Level Limited hum
This comparison does not assign a generated winner or score.
- Dose Range
- Melanotan-2
- 100–500 mcg
- PT-141 (Bremelanotide)
- 1.75–2 mg
- Frequency
- Once daily
- As needed
- Administration
- Subcutaneous injection
- Cycle Length
- 4-6 weeks
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Rapid (hours to days)
- Evidence Level
- Limited human trials
- Strong human trials (Phase 3 or FDA approved)
- Efficacy